Selank 5mg
5mgA synthetic peptide studied for anxiolytic (anti-anxiety) and nootropic (cognitive) properties in neuroscience research.
Overview
Selank is a synthetic heptapeptide derived from the immunomodulatory peptide tuftsin. It is a prominent reference compound in research into anxiety, stress, and cognition.
This product is supplied as 5mg of lyophilised powder for laboratory reconstitution and research use only.
Mechanism of action
Selank is studied for its modulation of GABAergic and serotonergic signalling, along with effects on the expression of brain-derived neurotrophic factor (BDNF) and the balance of monoamine neurotransmitters.
It also influences the expression of interleukins and enkephalin-degrading enzymes, which research links to its stress-regulating profile.
Research highlights
Selank has been studied in animal and clinical research for anxiolytic effects comparable to benzodiazepines but without sedation or dependence in the models examined.
Its nootropic profile makes it a common reference peptide in cognition and stress-response research.
Reference dosing
Research protocols use intranasal or subcutaneous administration 1-3x/day for cognition and stress studies, with cycles often running 2-4 weeks followed by breaks. This reflects published research protocols only.
Storage & handling
Store lyophilised vials refrigerated at 2-8C, protected from light. Keep reconstituted solution refrigerated and use per protocol.
Specifications
| Contents | Selank 5mg |
| Form | Lyophilised powder |
| Presentation | Single vial |
| Purity | >=99% (HPLC) |
| Reconstitution | Bacteriostatic water (not included) |
Frequently asked questions
What is Selank studied for?
It is studied for anxiolytic (anti-anxiety) and nootropic (cognitive-enhancing) effects in neuroscience research.
How is Selank administered in research?
Published protocols use intranasal or subcutaneous routes, typically 1-3 times per day over short cycles.